United Therapeutics Corporation

Unlock to Claim this listing
Add / Modify Company

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Tyvaso, an inhaled formulation of prostacyclin analogue treprostinil to enhance the exercise ability in PAH patients and pulmonary hypertension associated with interstitial lung disease (PH-ILD); Orenitram, a tablet dosage form of treprostinil to enhance the exercise capacity in PAH patients; Unituxin, a monoclonal antibody for treating high-risk neuroblastoma; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. The company also engages in developing Tyvaso DPI, a dry powder inhalation form of Tyvaso; Remunity Pump, a small, lightweight, durable pump and separate controller; RemoPro and Ralinepag for the treatment of PAH; Aurora-GT, a gene therapy product to rebuild the blood vessels in the lungs; and Tyvaso PERFECT and TETON studies, which are the studies of Tyvaso in patients with World Health Organization (WHO) Group 3 pulmonary hypertension associated with chronic obstructive pulmonary disease (PH-COPD).

Click to rate this company
[Total: 0 Average: 0]

3.5

Overall Excellence Rating

Industry

Healthcare

Category

Biotech & Pharmaceuticals

ESG/Ethical Impact

United Therapeutics is in the business of saving lives, and that is not limited to our focus on patients. We also put innovative efforts into mitigating our impact on the planet and prioritizing environmental stewardship. This focus has been a central part of our strategy for over a decade. The cornerstone of our commitment to our planet is demonstrated in the industry-leading design and construction of our facilities in Silver Spring, MD; Research Triangle Park (RTP), NC; and Melbourne and Jacksonville, FL.Our commitment to social responsibility is rooted in our founding as a mission-driven company, intent on developing therapies, and one day a cure, for the rare, life-threatening lung condition known as pulmonary arterial hypertension (PAH). To fulfill this mission, we have developed an ever expanding series of FDA-approved medicines and devices to treat PAH, and have launched Lung Biotechnology PBC, a public benefit corporation with the goal of using our innovative organ manufacturing programs to cure PAH and other diseases by creating an unlimited supply of transplantable lungs and other organs. To our knowledge, this is the first public benefit corporation subsidiary of a public biotech company.We strive to always operate with an eye toward corporate responsibility, environmental sustainability, and solid governance. These practices have long been embedded into our business at all levels. We have a strong tone at the top, with leaders who care deeply about improving the lives of patients, empowering our people, and making our planet and the communities in which we live and work better. We are guided by doing the right thing, while also relentlessly pushing to always do better. We also have an active, engaged, and diverse Board of Directors, which oversees our key business strategies and objectives, our risk management process, our compliance program, and key aspects of our corporate social responsibility program.We have dedicated teams to ensure that patients have access to our treatments. One team works with insurers to strive for the best possible coverage for our drugs, and we are proud of the results we have achieved. We also have a variety of options for patients who may still need financial assistance to pay for our treatments. And we have a dedicated team, ASSIST (Access Solutions and Support Team), that helps our patients and their families navigate this complex area. Our ASSIST Associates are ready to work with them, their health care providers, and specialty pharmacies to help them understand their insurance coverage, educate them about available financial assistance options, and answer their questions.One of our strategic objectives is to achieve our goals by doing the right thing and using the highest ethical standards. This is evidenced by our commitment to a robust compliance program, ethical operations, scientific integrity, responsible sourcing, and environmental sustainability. Ethics is one of our core values, and we continue to enhance our programs across all of these areas. One important aspect of our approach to business ethics is a well-defined set of Compliance Principles that outlines how we behave, and clear leadership attributes that we expect from all Unitherians.

Eligible Awards

Coming Soon

Claim Your Award Badges

Do you work with Us

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer.

Awards Received

2023

Revenues

$1,900,000,000.00

Website Traffic

Employee Rating

4

Customer Rating

3.7

Company Size

100-1000

ESG Risk Rating

3

We’re Happy to Help.

Do you have questions about your ranking, our projects, or why you’re not on the list?
Scroll to Top

Excellence In My Industry

This badge tells your customers, employees, partners, and other stakeholders that your company has met the criteria of our excellence certification in best practices across all pillars of business in your specific industry – from financial responsibility and results, sustainability, social responsibility, employee experience, customer satisfaction, ethics, and more.

Best Practice Certified

This badge tells your customers, employees, partners, and other stakeholders that your company has met the criteria of our excellence certification in best practices across all pillars of business – from financial responsibility and results, sustainability, social responsibility, employee experience, customer satisfaction, ethics, and more.

Best of Best Practices

This badge tells your customers, employees, partners, and other stakeholders that your company is one of the top 20 companies in your industry that has met the criteria for our excellence certification in best practices across all pillars of business – from financial responsibility and results, sustainability, social responsibility, employee experience, customer satisfaction, ethics, and more.

Newsweek Excellence 1000

This badge tells your customers, employees, partners, and other stakeholders that your company is one of the Top 1000 companies that demonstrate excellence across all pillars of business – from financial responsibility and results, sustainability, social responsibility, employee experience, customer satisfaction, ethics, and more.